Amlodipine Besylate Price in USA

United States: 75,190 USD/MT

In December 2023, the cost of amlodipine besylate in the United States peaked at $75,190 per metric ton in the fourth quarter. The country faced hurdles due to inflation and high interest rates, resulting in reduced consumer confidence and diminished product demand.

The latest report by IMARC Group, titled "Amlodipine Besylate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data" delivers a comprehensive analysis of amlodipine besylate prices on a global and regional scale, highlighting the pivotal factors contributing to price changes. This detailed examination includes spot price evaluations at key ports and an analysis of pricing structures, such as Ex Works, FOB, and CIF, across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Amlodipine Besylate Prices December 2023:

United States: 75,190 USD/MT
China: 73,845 USD/MT (USP, FDA)
Germany: 74,672 USD/MT (USP, FDA)

Report Offering:

Monthly Updates: Annual Subscription
Quarterly Updates: Annual Subscription
Biannually Updates: Annual Subscription

The study delves into the factors affecting amlodipine besylate price variations, including alterations in the cost of raw materials, the balance of supply and demand, geopolitical influences, and sector-specific developments.

The report also incorporates the most recent updates from the market, equipping stakeholders with the latest information on market fluctuations, regulatory modifications, and technological progress. It serves as an exhaustive resource for stakeholders, enhancing strategic planning and forecast capabilities.

Request For a Sample Copy of the Report: https://www.imarcgroup.com/amlodipine-besylate-pricing-report/requestsample

Amlodipine Besylate Price Trend- Q4 2023

The amlodipine besylate market's dynamics in the fourth quarter of 2023 were shaped by various economic and sector-specific factors across different regions. In North America, especially the United States, the market faced a downturn primarily due to persistent inflation and historically high interest rates, which eroded consumer confidence and reduced demand for amlodipine besylate. Similarly, in the APAC region, with China as a focal point, the market exhibited fluctuations driven by a mix of ample supply and weak demand from local and international markets. Europe's scenario echoed a similar sentiment where weakened demand, particularly from Germany, was influenced by inflationary pressures and higher interest rates set by the European Central Bank (ECB). This scenario was compounded by an abundant supply, which led providers to lower prices in an attempt to deplete stockpiles.

Amlodipine Besylate Market Analysis

The pricing trends of amlodipine besylate in December 2023 were indicative of the broader economic and industry-specific challenges that unfolded over the quarter. In North America, the pricing landscape was primarily impacted by the ongoing struggle with inflation and high-interest rates. This environment dampened consumer confidence, translating into decreased demand for amlodipine besylate. However, a slight improvement was noticed as inflationary pressures eased and consumer spending picked up slightly in November, though this did not significantly alter the year-over-year price comparison, leading to a minor decrease of 1% from the previous quarter. The market's bearish trend was reflective of the broader economic uncertainties affecting consumer behavior and spending patterns, particularly in the pharmaceutical sector where amlodipine besylate is a key component.

In contrast, the APAC region, particularly China, presented a complex interplay of supply and demand dynamics that influenced amlodipine besylate pricing. The quarter began with a decline in prices due to ample supply and reduced orders, both domestically and internationally. However, a brief reversal in November, driven by a pickup in demand from end-user industries and subsequent inventory replenishment, highlighted the market's volatility. Yet, this increase was short-lived as demand tapered off once again in December, leading to subdued trade activity and a drop in prices. This pattern of fluctuation was emblematic of the challenges within the manufacturing sector and the broader economic factors at play, including weak external demand and the ongoing adjustments within the global supply chain. The scenario underscored the delicate balance between supply and demand in determining the market pricing of Amlodipine Besylate, amidst a backdrop of economic recovery and uncertainty.

Browse Full Report: https://www.imarcgroup.com/amlodipine-besylate-pricing-report

Key Points Covered in the Amlodipine Besylate Pricing Report:

The report delivers the following key findings, alongside a comprehensive breakdown of prices by region:

Amlodipine Besylate Prices
Amlodipine Besylate Price Demand
Amlodipine Besylate Demand & Supply
Amlodipine Besylate Market Analysis
Demand Supply Analysis by Type
Demand Supply Analysis by Application
Demand Supply Analysis of Raw Materials
Amlodipine Besylate Price Analysis
Amlodipine Besylate Industry Drivers, Restraints, and Opportunities
Amlodipine Besylate News and Recent developments
Global Event Analysis
List of Key Players

Regional Price Analysis:

Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco

Browse More Pricing Reports By IMARC Group:

Note: The current country list is selective, detailed insights into additional countries can be obtained for clients upon request.

About Us:

IMARC is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145